Exsudatmanagementkapazität moderner Wundauflagen für die Therapie des Ulcus cruris venosum unter Kompressionstherapie

Abstract

Major components in the conservative treatment of patients with chronic venous leg ulcers are compression therapy and modern wound dressings. Both therapies are used simultaneously. Consequently it is important to know the exudate capacity of modern wound dressings changes during compression therapy. In the first part of our study we analyzed the maximum exudate capacity of 15 modern wound dressings. In the second part we showed that under compression stockings of class 2, a reduction of 44.08% and under compression stockings of class 3, a reduction of 50.49% occurred. In the third part we pointed out that all the investigated wound dressings released absorbed fluid when under compression. Again the effect was higher when using compression class 3 with 40.78% compared to compression class 2 with 40.50%. Our results show for the first time the broad variability of exudate capacity of modern wound dressings. Our results show that compression therapy has a considerable effect on the ability of modern wound dressings to absorb and retain exudate and suggests that more frequent changes may be required.

Investigation of adhesion of modern wound dressings: a comparative analysis of 56 different wound dressings

“…There exists no perfect wound dressing for every kind of wound or every phase of wound healing 9–11 . One aspect is the patient’s individual life situation, which should be considered when choosing an individual‐adapted therapy.…”

“…There exists no perfect wound dressing for every kind of wound or every phase of wound healing. [9][10][11] One aspect is the patient's individual life situation, which should be considered when choosing an individual-adapted therapy. For example, patients, who are unable to change their dressings for several days, should have dressings with stronger adhesion properties.…”

Non‐interventional study to investigate the efficacy and safety of Tegaderm™ Matrix in the treatment of patients with therapy‐refractory chronic wounds

“…Within the context of a complex treatment strategy of patients with chronic wounds targeted at the cause, the use of modern wound dressings is sensible, for example, to realize a moist wound environment with exudate management. It is suggested that in therapy‐refractory cases selection of a wound dressing might potentially achieve renewed induction of stagnant wound healing [8]. Studies to date indicate that Tegaderm™ Matrix can have a positive effect on previously stagnant wound healing [9].…”